Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesNew Anti-Rejection Drug Saves Money, Lives
Ivanhoe, 10/16/09
A newer, less expensive drug used to prevent organ rejection has been shown to be equally as effective and safe as its more expensive counterpart. In a study researchers compared the effectiveness of two drugs used to reduce the chances of rejection in kidney and pancreas transplants: alemtuzumab, a new drug that costs about $1,000 per treatment, and rabbit antithymocyte globulin, which costs about four times as much. Both drugs are used in short–term treatment to rapidly lower the immune system and thus prevent organ rejection.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Potential new heart attack biomarker uncovered
EurekAlert, 12/11/09
Pathological gambling may be successfully treated with medications for substance addiction
EurekAlert, 12/11/09
Common heart rhythm problem on the rise in the U.S.
Reuters, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor